Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | FDPS | P14324 | 1/20 | 0.41 |
| ▸ | FABP4 | P15090 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | WDR5 | P61964 | 1/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31668450 | 0.74 | ALDH1A1 (0.54) | L3MBTL1KDM4ETSHRCYP3A4MAPK1 | |
| SCHEMBL27504693 | 0.74 | ALDH1A1 (0.54) | L3MBTL1KDM4ETSHRCYP3A4MAPK1 | |
| SCHEMBL482904 | 0.74 | ALDH1A1 (0.47) | HPGDL3MBTL1KDM4ERAB9ATSHR | |
| SCHEMBL9729537 | 0.71 | KDM4E (0.46) | L3MBTL1KDM4EFABP4TSHRCASP1 | |
| Chrysene SCHEMBL28689979 | 0.67 | HPRT1 (0.67) | HPGDL3MBTL1KDM4ETSHRHIF1A | |
| Bicarbonate SCHEMBL5198606 | 0.66 | TSHR (0.79) | HPGDL3MBTL1KDM4ERAB9ATSHR | |
| SCHEMBL16794706 | 0.66 | MYC (0.46) | HPGDKDM4ETSHRMAPK1HSD17B10 | |
| Phenanthrene SCHEMBL11152558 | 0.66 | ALDH1A1 (0.63) | HPGDL3MBTL1KDM4ETSHRHIF1A | |
| SCHEMBL9697347 | 0.66 | FDPS (0.45) | HPGDL3MBTL1KDM4EFDPSRAB9A | |
| Phenanthrene SCHEMBL28735113 | 0.65 | ALDH1A1 (0.71) | HPGDL3MBTL1KDM4ETSHRHIF1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1646609-B1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2009-10-14 | — | — | EP | disclosed |
| US-7262306-B2 | Chemiluminescent compounds and their use | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2007-08-28 | — | — | US | disclosed |
| US-20060199223-A1 | storage stability; immunoassays | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2006-09-07 | — | — | US | disclosed |
| EP-1646609-A1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | Roche Diagnostics GmbH (DE) | 2006-04-19 | — | — | EP | disclosed |
| WO-2005005385-A1 | NOVEL CHEMILUMINESCENT COMPOUNDS AND THEIR USE | ROCHE DIAGNOSTICS GMBH (DE) | 2005-01-20 | — | — | WO | disclosed |
| EP-1496050-A1 | Novel chemiluminescent compounds and their use | Roche Diagnostics GmbH (DE) | 2005-01-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060199223-A1 | storage stability; immunoassays | SHBG, SELL, XIAP | HPGD 895/4885L3MBTL1 1754/4885KDM4E 3237/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.